Firms

Dendrion Ventures

Dendrion Ventures

Chicago, Illinois, United States

Dendrion Ventures, LLC is a Chicago medical-technology investor whose own website describes an evergreen-capital strategy. SEC2026 filings identify the LLC as manager of dedicated venture vehicles, including MadSci and Innoblative; separate Re-Emerge and Epitel vehicles name Tyler Wanke as executive. Northwestern's Kellogg Healthcare Club identifies Wanke as Dendrion's managing director. ReEmerge's September2026 SeriesA announcement confirms the firm as a neuroscience investor. Public sources do not publish a complete team directory, manager founding date or aggregate closed evergreen corpus. Individual SPV raises and fundraising targets are recorded separately and are not treated as the manager's company-level investment tickets.

Founded
—
Type
Venture capital

Funds4

  • Dendrion Innoblative 1, LLC$60K

    Dendrion Innoblative 1, LLC. Dedicated2026 venture vehicle. Announcement field is public filing date, not a guessed final closing day. SEC filing reports entire offered amount sold and zero remaining; does not prove this amount equals the manager's direct company ticket.

  • Dendrion MadSci 1, LLC$241K

    Dendrion MadSci 1, LLC. Dedicated2026 venture vehicle. Announcement field is public filing date, not a guessed final closing day. SEC filing reports entire offered amount sold and zero remaining; does not prove this amount equals the manager's direct company ticket.

  • Dendrion Epitel 1, LLC—

    Dendrion Epitel 1, LLC. Dedicated2026 venture vehicle. Announcement field is public filing date, not a guessed final closing day. Legal vehicle and firstsale2026-05-29 are verified in reproduced SEC filing; finalclosed corpus not independently verified and remains NULL.

  • Dendrion Re-Emerge 1, LLC—

    Dendrion Re-Emerge 1, LLC. Dedicated2026 venture vehicle. Announcement field is public filing date, not a guessed final closing day. SEC reports USD352618 sold toward USD1000000 offering at filing; finalclosed amount remains NULL. Firstsale2026-05-07 is not finalclose.

Team

Operations and support

Tyler WankeTyler WankeManaging Director

Co-investing

415 Capital
Santé Ventures
The Vertical Group

Investments